Femasys IncFEMY
Price$2.10

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Dec 2025
Market Price $2.10Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 63.1%/yr (balance of the path).49.4% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 651.4%Yr 739.6%Yr 827.9%Yr 916.1%Yr 104.3%
63.1% → 4.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.2%Yr 124.1%Yr 133.9%Yr 143.8%Yr 153.7%Yr 163.5%Yr 173.4%Yr 183.3%Yr 193.1%Yr 203.0%
4.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)4.3%
Discount rate (cost of equity) 9.4%
Volatility vs market (adjusted beta)1.00

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetFemasys IncFEMYHealth Care
Valuation
P/E—
P/S9.3×
P/B1.3×
EV / Revenue6.7×
EV / EBITDA—
Profitability
Gross margin62.0%
Operating margin-767.0%
Net margin-812.3%
FCF margin-837.9%
Returns
ROE-317.3%
ROA-89.9%
ROIC—
Growth
Revenue growth (YoY)40.8%
5-yr fwd EPS growth49.4%
Financial strength
Debt / Equity0.54×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.